The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine

• Auteurs principaux: Tyler C. Beck (Auteur), Kyle R. Beck (Auteur), Calvin B. Holloway (Auteur), Richard A. Hemings (Auteur), Thomas A. Dix (Auteur), Russell A. Norris (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The emergence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) in China, reported to the World Health Organization on December 31, 2019, has led to a large global pandemic and is a major public health issue. As a result, there are more than 200 clinical trials of COVID-19...